<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="resveratrol, emodin, and quercetin on the consequences of dialysis in" exact="chronic kidney disease" post="(CKD) patients were explored. The protective features of silymarin"/>
 <result pre="to double by 2030 because of increasing the risk of" exact="obesity" post="and diabetes mellitus among the different population and population"/>
 <result pre="by 2030 because of increasing the risk of obesity and" exact="diabetes mellitus" post="among the different population and population aging in many"/>
 <result pre="dialysis patients remain high due to its complications such as" exact="cardiovascular disease" post="[6,7]. Oxidative stress, a pathological state, is associated with"/>
 <result pre="stress has also an important role in the promotion of" exact="atherosclerosis" post="in ESRD patients [11]. Moreover, oxidative stress and inflammatory"/>
 <result pre="organ failure [36]. Hyper-inflammation in chronic HD patients leads to" exact="cardiovascular disease" post="and increases the mortality rate [37,38]. The accumulation of"/>
 <result pre="attenuate the damage induced by oxidative stress in organs through" exact="suppression" post="of the initiation or progression of oxidative chain reaction,"/>
 <result pre="the antioxidant endogenous enzyme CAT in red blood cells and" exact="anemia" post="due to hemoglobin values were improved in the silymarin"/>
 <result pre="[79]. The beneficial effects of curcumin on animal models of" exact="nephropathy" post="have been confirmed in several studies. The supplementation of"/>
 <result pre="for 2â€‰months in patients with diabetic CKD, 39% reduction in" exact="proteinuria" post="and decreased serum levels of transforming growth factor-beta (TGF-Î²)"/>
 <result pre="and TNF-Î± were reported [86]. Similarly, curcumin supplementation decreased significant" exact="proteinuria" post="in patients with lupus nephritis [87]. In limited studies,"/>
 <result pre="Similarly, curcumin supplementation decreased significant proteinuria in patients with lupus" exact="nephritis" post="[87]. In limited studies, the antioxidant and anti-inflammatory effects"/>
 <result pre="attenuated oxidative stress-mediated renal damage in animal models of septic" exact="nephropathy" post="[94], ischemia/reperfusion acute kidney injury [95], nephrotoxicity induced by"/>
 <result pre="[96], cisplatin [97], and cyclosporin [98], as well as diabetic" exact="nephropathy" post="[99]. Different intracellular signaling molecules in kidney cells are"/>
 <result pre="reduced renal hypertrophy and hyperfiltration in rat models of diabetic" exact="nephropathy" post="[113]. Nephroprotective effects of emodin against diabetic renal injury"/>
 <result pre="attributed to activation of PI3K/Akt/glycogen synthase kinase 3Î² signaling pathway" exact="suppression" post="of inflammation, Bax/Caspase3 pathway [114], and phosphorylation of P38"/>
 <result pre="Also, in diabetic nephropathy, quercetin improves the renal function by" exact="suppression" post="of progression of renal fibrosis and mammalian target of"/>
 <result pre="tubular epithelial cells via upregulation of PTEN and TIMP3, and" exact="suppression" post="of miR21, which highlights the anti-fibrotic feature of quercetin"/>
 <result pre="resveratrol, emodin, and quercetin on the consequences of dialysis in" exact="chronic kidney disease" post="(CKD) patients were explored in this study. It seems"/>
 <result pre="document on KDIGO guidelines for the assessment and treatment of" exact="chronic kidney disease." post="Nefrologia. 2014;34(3):302â€&quot;316.24798565 2FraserSD, BlakemanT.Chronic kidney disease: identification and management"/>
 <result pre="Obs Res. 2016;7:21â€&quot;32.27822135 3ElshahatS, CockwellP, MaxwellAP, et al.The impact of" exact="chronic kidney disease" post="on developed countries from a health economics perspective: a"/>
 <result pre="de VinuesaSG, et al.Oxidative stress and inflammation, a link between" exact="chronic kidney disease" post="and cardiovascular disease. Kidney Int Suppl. 2008;74(111):S4â€&quot;S9. 10FujiiH, GotoS,"/>
 <result pre="stress and inflammation, a link between chronic kidney disease and" exact="cardiovascular disease." post="Kidney Int Suppl. 2008;74(111):S4â€&quot;S9. 10FujiiH, GotoS, FukagawaM.Role of uremic"/>
 <result pre="therapy. Semin Dial. 2009;22(6):636â€&quot;643.20017834 14MarajM, KuÅ›nierz-CabalaB, DumnickaP, et al.Malnutrition, inflammation," exact="atherosclerosis" post="syndrome (MIA) and diet recommendations among end-stage renal disease"/>
 <result pre="2017;31(10):1527â€&quot;1532. 20L GuptaK, SahniN.Dietary antioxidents and oxidative stress in predialysis" exact="chronic kidney disease" post="patients. J Nephropathol. 2012;1(3):134â€&quot;142.24475404 21DaiL, GolembiewskaE, LindholmB, et al.End-stage"/>
 <result pre="culprit underlying chronic low-grade inflammation and systemic oxidative stress in" exact="chronic kidney disease." post="J Am Soc Nephrol. 2005;16(8):2431â€&quot;2438.15987755 31BorawskiJ.Myeloperoxidase as a marker"/>
 <result pre="inflammation. Hemodial Int. 2005;9(1):37â€&quot;46.16191052 37Pecoits-FilhoR, LindholmB, StenvinkelP.The malnutrition, inflammation, and" exact="atherosclerosis" post="(MIA) syndrome - the heart of the matter. Nephrol"/>
 <result pre="2019;5(2):e21-eâ€&quot;e21. 53AlirezaeiA, ArganiH, AsgharpourM, et al.An update on allopurinol and" exact="kidney failure;" post="new trend for an old drug. J Renal Inj"/>
 <result pre="al.Effect of silymarin on kidneys of rats suffering from alloxan-induced" exact="diabetes mellitus." post="Phytomedicine. 2010;17(14):1090â€&quot;1094.20579862 65FÃ©herJ, LengyelG.Silymarin in the prevention and treatment"/>
 <result pre="in the prevention and treatment of liver diseases and primary" exact="liver cancer." post="Curr Pharm Biotechnol. 2012;13(1):210â€&quot;217.21466434 66El-ShitanyNA, El-HaggarS, El-DesokyK.Silymarin prevents adriamycin-induced"/>
 <result pre="al.Effect of addition of silymarin to renin-angiotensin system inhibitors on" exact="proteinuria" post="in type 2 diabetic patients with overt nephropathy: a"/>
 <result pre="et al.Curcumin ameliorates kidney function and oxidative stress in experimental" exact="chronic kidney disease." post="Basic Clin Pharmacol Toxicol. 2018;122(1):65â€&quot;73.28561324 82KimKS, LimH-J, LimJS, et"/>
 <result pre="de Oliveira LealV, BorgesNA, et al.Curcumin-A promising nutritional strategy for" exact="chronic kidney disease" post="patients. J Funct Foods. 2018;40:715â€&quot;721. 84LiY, ZhangJ, LiuH, et"/>
 <result pre="YuHR, et al.The effects of resveratrol in the treatment of" exact="metabolic syndrome." post="Int J Mol Sci. 2019;20(3):535. 93SadiG, ÅžahinG, BostancÄ±A.Modulation of"/>
 <result pre="of resveratrol supplementation in Nrf2 and NF-ÎºB expressions in nondialyzed" exact="chronic kidney disease" post="patients: a randomized, double-blind, placebo-controlled, crossover clinical trial. J"/>
 <result pre="et al.Recovery of bone and muscle mass in patients with" exact="chronic kidney disease" post="and iron overload on hemodialysis and taking combined supplementation"/>
 <result pre="et al.Emodin inhibits growth and induces apoptosis in an orthotopic" exact="hepatocellular carcinoma" post="model by blocking activation of STAT3. Br J Pharmacol."/>
 <result pre="Med]. 1993;13(5):61â€&quot;62. 114JingD, BaiH, YinS.Renoprotective effects of emodin against diabetic" exact="nephropathy" post="in rat models are mediated via PI3K/Akt/GSK-3Î² and Bax/caspase-3"/>
 <result pre="of phosphorylation of p38 MAPK involved in the protection of" exact="nephropathy" post="by emodin in diabetic rats. Eur J Pharmacol. 2006;553(1â€&quot;3):297â€&quot;303.17074319"/>
 <result pre="and protects the kidney in a rat model of adenine-induced" exact="chronic kidney disease." post="Med Sci Monit. 2018;24:4760â€&quot;4766.29987270 124Vicente-VicenteL, PrietoM, MoralesA.Eficacia y seguridad"/>
</results>
